All News
Filter News
Found 509 articles
-
Innate Pharma Reports Full Year 2019 Financial Results and Business Update
3/10/2020
Innate Pharma SA reported its consolidated financial results for the year ending December 31, 2019. The consolidated financial statements are attached to this press release..
-
BioSpace Global Roundup, March 5
3/5/2020
Life sciences companies from across the globe provide updates on their businesses and pipelines. -
BioInvent and Transgene to Present Data on BT-001, an Oncolytic Virus Encoding for an Anti-CTLA4 Antibody, at Upcoming Congresses
3/3/2020
Oncolytic virus design and preclinical data to be presented at ESMO TAT, IO Summit Europe, Keystone Symposium and AACR 2020
-
Transgene and BioInvent to Present Data on BT-001, an Oncolytic Virus Encoding for an Anti-CTLA4 Antibody, at Upcoming Congresses
3/3/2020
Oncolytic Virus Design and Preclinical Data to be Presented at ESMO TAT, IO Summit Europe, Keystone Symposium and AACR 2020
-
IO Biotech Announces Positive Outcome of Interim Analysis of Phase 2 Randomized Trial in First Line Non-small Cell Lung Cancer
2/25/2020
Data position the company to start potential registrational trials with two drugs in two tumor types
-
Novo Seeds Portfolio Company IO Biotech Announces Positive Outcome of Interim Analysis of Phase 2 Trial in First Line Non-small Cell Lung Cancer
2/25/2020
Data position the company to start potential registrational trials with two drugs in two tumor types
-
NeoImmuneTech Appoints Gene Namgoong as Chief Operating Officer
1/30/2020
NeoImmuneTech, Inc., a T cell-focused immunotherapeutics company, today announced the appointment of Gene Namgoong as Chief Operating Officer (COO).
-
Grey Wolf Therapeutics completes £2.5 million ($3.3 million) Series A2 financing to accelerate development of therapies targeting ERAP2
1/9/2020
Grey Wolf targets ERAP antigen presentation pathways with the aim of ‘illuminating’ non-responsive tumors for attack and destruction by the immune system
-
Savonix to Present at Upcoming Conferences During JPM Healthcare Week in San Francisco
1/7/2020
Savonix, a digital platform for real-time cognitive insights in clinical trials and clinical care, today announced that Dr. Mylea Charvat, CEO and Founder, will present at the following events during the most important week for healthcare investors on January 13-15, 2020, in San Francisco, CA.
-
Yisheng Biopharma and Tavotek Biotherapeutics Announce Strategic Research Alliance for Development of YS-ON-001/002 and Tavo-301/303 Combination Therapy for Cancer Treatment
1/6/2020
Yisheng Biopharma Co., Ltd. and Tavotek Biotherapeutics announced that the companies have entered into a strategic research alliance and collaborate in the development involving their lead assets in oncology.
-
BioLineRx Announces Updated Phase 2a Data From Triple Combination Arm of COMBAT/KEYNOTE-202 Study in Patients With Second-line Metastatic Pancreatic Cancer
12/13/2019
BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology, announced today updated data from the triple combination arm of the ongoing Phase 2a COMBAT/KEYNOTE-202 study.
-
BioLineRx Announces Preliminary Phase 2a Data from Triple Combination Arm of COMBAT/KEYNOTE-202 Study in Second Line Patients With Metastatic Pancreatic Cancer
12/5/2019
Combination of BL-8040, KEYTRUDA® and chemotherapy showed high level of disease control, including 4 partial responders and 8 patients with stable disease out of 15 evaluable patients
-
Metastatic Breast Cancer Alliance Announces Release of MBC Connect 2.0
12/2/2019
National Nonprofit's Updated Mobile App and Online Platform will Identify Potential Clinical Trial Matches for Patients
-
BioSpace Movers & Shakers, Nov. 29
11/29/2019
Pharma and life science companies strengthen their leadership teams and boards of directors with this week's appointments. -
Aligos Therapeutics Welcomes Kathleen Sereda Glaub to its Board of Directors
11/25/2019
Aligos Therapeutics, Inc., a biotechnology company focused on the development of targeted therapies for hepatologic diseases and viral infections, including chronic hepatitis B, nonalcoholic steatohepatitis, and hepatocellular carcinoma, announced the appointment of Kathleen Sereda Glaub to the company’s board of directors.
-
Innate Pharma third quarter 2019 report
11/13/2019
Cash, cash equivalents and financial assets of the Company amounted to €215.2 millioni
-
BERG Presents Data Demonstrating That BPM31510 Promotes Cytotoxic T-cell Function And Influences Checkpoint Receptor Expression Patterns To Potentially Synergize Anti-Cancer Effect In Combination With I/O Therapies
11/8/2019
BERG, a clinical stage biopharmaceutical company that uses artificial intelligence (AI) to discover the underlying biology of disease, today announced results from a study of its investigational drug BPM31510 (ubidecarenone) characterizing its immunomodulatory properties ex vivo and in tumor bearing mice
-
Twist Biopharma Implements Genedata Biologics to Advance Synthetic Biology-driven Antibody Discovery
11/8/2019
First-in-class software platform digitalizes Twist Biopharma’s innovative antibody lead identification and optimization
-
Metastatic Breast Cancer Alliance Brings Awareness to Clinical Trials in Advance of the Release of MBC Connect 2.0
10/21/2019
National Nonprofit’s Enhanced Mobile App and Online Platform will Potentially Match Patients with Clinical Trials
-
binx health Announces First Patients Benefiting From Single-Visit Test and Treatment for Chlamydia and Gonorrhea
9/23/2019
binx health, the pioneer in anywhere, anytime testing for women's health, today announced the first real-world use of the binx io platform, delivering same-visit diagnosis and treatment for chlamydia (CT) and gonorrhea (NG)—the two most tested-for sexually transmitted infections (STIs) globally.